Medicus Pharma Ltd. (MDCX)
0.1682
+0.01
(+4.47%)
USD |
NASDAQ |
Oct 05, 16:00
0.1682
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Enterprise Value : 14.27M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 14.27M |
| October 01, 2026 | 14.03M |
| September 30, 2026 | 14.27M |
| September 29, 2026 | 14.00M |
| September 28, 2026 | 13.73M |
| September 25, 2026 | 13.75M |
| September 24, 2026 | 14.14M |
| September 23, 2026 | 14.17M |
| September 22, 2026 | 14.45M |
| September 21, 2026 | 14.87M |
| September 18, 2026 | 14.83M |
| September 17, 2026 | 14.85M |
| September 16, 2026 | 13.98M |
| September 15, 2026 | 13.73M |
| September 14, 2026 | 14.17M |
| September 11, 2026 | 14.37M |
| September 10, 2026 | 14.29M |
| September 09, 2026 | 14.84M |
| September 08, 2026 | 14.81M |
| September 04, 2026 | 14.93M |
| September 03, 2026 | 14.84M |
| September 02, 2026 | 20.22M |
| September 01, 2026 | 19.70M |
| August 31, 2026 | 20.33M |
| August 28, 2026 | 20.09M |
| Date | Value |
|---|---|
| August 27, 2026 | 20.70M |
| August 26, 2026 | 20.74M |
| August 25, 2026 | 20.29M |
| August 24, 2026 | 20.07M |
| August 21, 2026 | 20.94M |
| August 20, 2026 | 20.96M |
| August 19, 2026 | 20.50M |
| August 18, 2026 | 20.42M |
| August 17, 2026 | 20.23M |
| August 14, 2026 | 21.44M |
| August 13, 2026 | 25.88M |
| August 12, 2026 | 24.50M |
| August 11, 2026 | 25.39M |
| August 10, 2026 | 23.93M |
| August 07, 2026 | 22.61M |
| August 06, 2026 | 23.09M |
| August 05, 2026 | 22.44M |
| August 04, 2026 | 22.87M |
| August 03, 2026 | 22.69M |
| July 31, 2026 | 21.14M |
| July 30, 2026 | 20.38M |
| July 29, 2026 | 20.83M |
| July 28, 2026 | 21.43M |
| July 27, 2026 | 23.73M |
| July 24, 2026 | 26.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.725B |
| enGene Therapeutics, Inc. | -103.12M |
| Xenon Pharmaceuticals, Inc. | 2.754B |
| Psyence Biomedical Ltd. | -- |
| AVITA Medical, Inc. | 430.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.440M |
| Total Expenses (Quarterly) | 8.392M |
| EPS Diluted (Quarterly) | -0.1524 |
| Earnings Yield | -963.6% |
| Normalized Earnings Yield | -810.23 |